PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Translational Research Unit, National Institute for Infectious Diseases (INMI), \'Lazzaro Spallanzani\'-IRCCS, Rome, Italy. Electronic address: delia.goletti@inmi.it.\', \'Translational Research Unit, National Institute for Infectious Diseases (INMI), \'Lazzaro Spallanzani\'-IRCCS, Rome, Italy.\', \'QIAGEN Manchester Ltd, Manchester, UK.\', \'Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore; Singapore Immunology Network, A∗STAR, Singapore.\', \'QIAGEN Inc., Germantown, MD, USA.\', \'Former QIAGEN Employee, 2005 Mada Residences, Downtown Dubai, PO Box 50502, United Arab Emirates.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.\', \'QIAGEN Manchester Ltd, Manchester, UK; Department of Infectious Diseases and Immunity, Imperial College, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1198-743X(21)00378-510.1016/j.cmi.2021.07.005
?:doi
?:hasPublicationType
?:journal
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34256141
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all